|
SFRS13A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0167201242316E-12 |
| Normal-vs-Stage2 |
1.94633198447036E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
8.35199687188037E-11 |
| Stage1-vs-Stage2 |
2.937700E-02 |
| Stage1-vs-Stage3 |
4.776100E-04 |
| Stage1-vs-Stage4 |
2.117900E-02 |
| Stage2-vs-Stage3 |
6.922000E-01 |
| Stage2-vs-Stage4 |
9.008400E-01 |
| Stage3-vs-Stage4 |
8.269000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.56110999999237E-05 |
| Normal-vs-Asian |
8.97620000550603E-08 |
| Caucasian-vs-AfricanAmerican |
7.059000E-01 |
| Caucasian-vs-Asian |
2.224600E-01 |
| AfricanAmerican-vs-Asian |
6.758800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76220038561326E-10 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.273000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.77019543257506E-11 |
| Normal-vs-Age(41-60Yrs) |
2.53130849614536E-14 |
| Normal-vs-Age(61-80Yrs) |
1.626032641866E-12 |
| Normal-vs-Age(81-100Yrs) |
5.51009999999463E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.196450E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.011300E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.015000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.874970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.920200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.357800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.784150E-04 |
| Classical-VS-Follicular |
3.221000E-01 |
| Classical-VS-Other |
2.121600E-01 |
| Classical-VS-Normal |
1.66378022470326E-12 |
| Tall-VS-Follicular |
1.937680E-02 |
| Tall-VS-Other |
5.155800E-02 |
| Tall-VS-Normal |
2.16493489801906E-14 |
| Follicular-VS-Other |
1.993770E-01 |
| Follicular-VS-Normal |
8.27229951205766E-10 |
| Other-VS-Normal |
8.395800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
1.28180000003031E-06 |
| N0-vs-N1 |
2.018600E-01 |
|
|
